nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A5—Teniposide—lymphatic system cancer	0.166	0.257	CbGbCtD
Oxcarbazepine—CYP2C19—Teniposide—lymphatic system cancer	0.134	0.207	CbGbCtD
Oxcarbazepine—CYP3A5—Vincristine—lymphatic system cancer	0.08	0.124	CbGbCtD
Oxcarbazepine—CYP3A4—Cytarabine—lymphatic system cancer	0.0658	0.102	CbGbCtD
Oxcarbazepine—CYP3A4—Teniposide—lymphatic system cancer	0.0648	0.1	CbGbCtD
Oxcarbazepine—ALB—Methotrexate—lymphatic system cancer	0.0603	0.0931	CbGbCtD
Oxcarbazepine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0453	0.07	CbGbCtD
Oxcarbazepine—CYP3A4—Vincristine—lymphatic system cancer	0.0312	0.0482	CbGbCtD
Oxcarbazepine—Angiopathy—Vincristine—lymphatic system cancer	0.000527	0.0015	CcSEcCtD
Oxcarbazepine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000527	0.0015	CcSEcCtD
Oxcarbazepine—Diarrhoea—Teniposide—lymphatic system cancer	0.000526	0.00149	CcSEcCtD
Oxcarbazepine—Chest pain—Bleomycin—lymphatic system cancer	0.000517	0.00147	CcSEcCtD
Oxcarbazepine—Myalgia—Bleomycin—lymphatic system cancer	0.000517	0.00147	CcSEcCtD
Oxcarbazepine—Alopecia—Vincristine—lymphatic system cancer	0.000514	0.00146	CcSEcCtD
Oxcarbazepine—Back pain—Carmustine—lymphatic system cancer	0.000513	0.00145	CcSEcCtD
Oxcarbazepine—Discomfort—Bleomycin—lymphatic system cancer	0.000511	0.00145	CcSEcCtD
Oxcarbazepine—Mental disorder—Vincristine—lymphatic system cancer	0.000509	0.00144	CcSEcCtD
Oxcarbazepine—Chills—Mitoxantrone—lymphatic system cancer	0.000508	0.00144	CcSEcCtD
Oxcarbazepine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000508	0.00144	CcSEcCtD
Oxcarbazepine—Urine output increased—Methotrexate—lymphatic system cancer	0.000508	0.00144	CcSEcCtD
Oxcarbazepine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000506	0.00143	CcSEcCtD
Oxcarbazepine—Alopecia—Mitoxantrone—lymphatic system cancer	0.0005	0.00142	CcSEcCtD
Oxcarbazepine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.0005	0.00142	CcSEcCtD
Oxcarbazepine—Confusional state—Bleomycin—lymphatic system cancer	0.0005	0.00142	CcSEcCtD
Oxcarbazepine—Vision blurred—Carmustine—lymphatic system cancer	0.000499	0.00142	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000498	0.00141	CcSEcCtD
Oxcarbazepine—Tremor—Carmustine—lymphatic system cancer	0.000497	0.00141	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000495	0.00141	CcSEcCtD
Oxcarbazepine—Infection—Bleomycin—lymphatic system cancer	0.000492	0.0014	CcSEcCtD
Oxcarbazepine—Back pain—Vincristine—lymphatic system cancer	0.000489	0.00139	CcSEcCtD
Oxcarbazepine—Vomiting—Teniposide—lymphatic system cancer	0.000489	0.00139	CcSEcCtD
Oxcarbazepine—Agitation—Carmustine—lymphatic system cancer	0.000487	0.00138	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000485	0.00138	CcSEcCtD
Oxcarbazepine—Asthenia—Fludarabine—lymphatic system cancer	0.000485	0.00138	CcSEcCtD
Oxcarbazepine—Rash—Teniposide—lymphatic system cancer	0.000485	0.00138	CcSEcCtD
Oxcarbazepine—Dermatitis—Teniposide—lymphatic system cancer	0.000484	0.00137	CcSEcCtD
Oxcarbazepine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000482	0.00137	CcSEcCtD
Oxcarbazepine—Headache—Teniposide—lymphatic system cancer	0.000482	0.00137	CcSEcCtD
Oxcarbazepine—Pruritus—Fludarabine—lymphatic system cancer	0.000478	0.00136	CcSEcCtD
Oxcarbazepine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000478	0.00136	CcSEcCtD
Oxcarbazepine—Back pain—Mitoxantrone—lymphatic system cancer	0.000477	0.00135	CcSEcCtD
Oxcarbazepine—Leukopenia—Carmustine—lymphatic system cancer	0.000474	0.00135	CcSEcCtD
Oxcarbazepine—Anorexia—Bleomycin—lymphatic system cancer	0.000472	0.00134	CcSEcCtD
Oxcarbazepine—Agitation—Vincristine—lymphatic system cancer	0.000465	0.00132	CcSEcCtD
Oxcarbazepine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000464	0.00132	CcSEcCtD
Oxcarbazepine—Polyuria—Methotrexate—lymphatic system cancer	0.000464	0.00132	CcSEcCtD
Oxcarbazepine—Hypotension—Bleomycin—lymphatic system cancer	0.000463	0.00131	CcSEcCtD
Oxcarbazepine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000462	0.00131	CcSEcCtD
Oxcarbazepine—Convulsion—Carmustine—lymphatic system cancer	0.000459	0.0013	CcSEcCtD
Oxcarbazepine—Hypertension—Carmustine—lymphatic system cancer	0.000458	0.0013	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000457	0.0013	CcSEcCtD
Oxcarbazepine—Nausea—Teniposide—lymphatic system cancer	0.000457	0.0013	CcSEcCtD
Oxcarbazepine—Vertigo—Vincristine—lymphatic system cancer	0.000455	0.00129	CcSEcCtD
Oxcarbazepine—Leukopenia—Vincristine—lymphatic system cancer	0.000453	0.00128	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000451	0.00128	CcSEcCtD
Oxcarbazepine—Myalgia—Carmustine—lymphatic system cancer	0.000451	0.00128	CcSEcCtD
Oxcarbazepine—Chest pain—Carmustine—lymphatic system cancer	0.000451	0.00128	CcSEcCtD
Oxcarbazepine—Anxiety—Carmustine—lymphatic system cancer	0.00045	0.00128	CcSEcCtD
Oxcarbazepine—Malaise—Mitoxantrone—lymphatic system cancer	0.000444	0.00126	CcSEcCtD
Oxcarbazepine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000442	0.00125	CcSEcCtD
Oxcarbazepine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000441	0.00125	CcSEcCtD
Oxcarbazepine—Convulsion—Vincristine—lymphatic system cancer	0.000438	0.00124	CcSEcCtD
Oxcarbazepine—Hypertension—Vincristine—lymphatic system cancer	0.000437	0.00124	CcSEcCtD
Oxcarbazepine—Confusional state—Carmustine—lymphatic system cancer	0.000436	0.00124	CcSEcCtD
Oxcarbazepine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000431	0.00122	CcSEcCtD
Oxcarbazepine—Myalgia—Vincristine—lymphatic system cancer	0.000431	0.00122	CcSEcCtD
Oxcarbazepine—Visual disturbance—Methotrexate—lymphatic system cancer	0.00043	0.00122	CcSEcCtD
Oxcarbazepine—Cough—Mitoxantrone—lymphatic system cancer	0.00043	0.00122	CcSEcCtD
Oxcarbazepine—Infection—Carmustine—lymphatic system cancer	0.00043	0.00122	CcSEcCtD
Oxcarbazepine—Vomiting—Fludarabine—lymphatic system cancer	0.00043	0.00122	CcSEcCtD
Oxcarbazepine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000427	0.00121	CcSEcCtD
Oxcarbazepine—Rash—Fludarabine—lymphatic system cancer	0.000426	0.00121	CcSEcCtD
Oxcarbazepine—Dermatitis—Fludarabine—lymphatic system cancer	0.000426	0.00121	CcSEcCtD
Oxcarbazepine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000425	0.00121	CcSEcCtD
Oxcarbazepine—Pain—Bleomycin—lymphatic system cancer	0.000424	0.0012	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000423	0.0012	CcSEcCtD
Oxcarbazepine—Headache—Fludarabine—lymphatic system cancer	0.000423	0.0012	CcSEcCtD
Oxcarbazepine—Tachycardia—Carmustine—lymphatic system cancer	0.000422	0.0012	CcSEcCtD
Oxcarbazepine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000419	0.00119	CcSEcCtD
Oxcarbazepine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000419	0.00119	CcSEcCtD
Oxcarbazepine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000419	0.00119	CcSEcCtD
Oxcarbazepine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000418	0.00119	CcSEcCtD
Oxcarbazepine—Lethargy—Methotrexate—lymphatic system cancer	0.000416	0.00118	CcSEcCtD
Oxcarbazepine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000414	0.00118	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000413	0.00117	CcSEcCtD
Oxcarbazepine—Anorexia—Carmustine—lymphatic system cancer	0.000412	0.00117	CcSEcCtD
Oxcarbazepine—Infection—Vincristine—lymphatic system cancer	0.00041	0.00116	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000408	0.00116	CcSEcCtD
Oxcarbazepine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000405	0.00115	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000405	0.00115	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000404	0.00115	CcSEcCtD
Oxcarbazepine—Hypotension—Carmustine—lymphatic system cancer	0.000404	0.00115	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000402	0.00114	CcSEcCtD
Oxcarbazepine—Nausea—Fludarabine—lymphatic system cancer	0.000401	0.00114	CcSEcCtD
Oxcarbazepine—Infection—Mitoxantrone—lymphatic system cancer	0.000399	0.00113	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000399	0.00113	CcSEcCtD
Oxcarbazepine—Shock—Mitoxantrone—lymphatic system cancer	0.000396	0.00112	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000394	0.00112	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000394	0.00112	CcSEcCtD
Oxcarbazepine—Urticaria—Bleomycin—lymphatic system cancer	0.000394	0.00112	CcSEcCtD
Oxcarbazepine—Anorexia—Vincristine—lymphatic system cancer	0.000394	0.00112	CcSEcCtD
Oxcarbazepine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000392	0.00111	CcSEcCtD
Oxcarbazepine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000392	0.00111	CcSEcCtD
Oxcarbazepine—Insomnia—Carmustine—lymphatic system cancer	0.000391	0.00111	CcSEcCtD
Oxcarbazepine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000391	0.00111	CcSEcCtD
Oxcarbazepine—Irritability—Methotrexate—lymphatic system cancer	0.000389	0.0011	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000389	0.0011	CcSEcCtD
Oxcarbazepine—Mood swings—Methotrexate—lymphatic system cancer	0.000386	0.0011	CcSEcCtD
Oxcarbazepine—Hypotension—Vincristine—lymphatic system cancer	0.000386	0.00109	CcSEcCtD
Oxcarbazepine—Dyspnoea—Carmustine—lymphatic system cancer	0.000386	0.00109	CcSEcCtD
Oxcarbazepine—Somnolence—Carmustine—lymphatic system cancer	0.000385	0.00109	CcSEcCtD
Oxcarbazepine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000383	0.00109	CcSEcCtD
Oxcarbazepine—Ataxia—Methotrexate—lymphatic system cancer	0.000383	0.00109	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000376	0.00107	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000376	0.00107	CcSEcCtD
Oxcarbazepine—Decreased appetite—Carmustine—lymphatic system cancer	0.000376	0.00107	CcSEcCtD
Oxcarbazepine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000376	0.00107	CcSEcCtD
Oxcarbazepine—Insomnia—Vincristine—lymphatic system cancer	0.000373	0.00106	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000373	0.00106	CcSEcCtD
Oxcarbazepine—Pain—Carmustine—lymphatic system cancer	0.00037	0.00105	CcSEcCtD
Oxcarbazepine—Constipation—Carmustine—lymphatic system cancer	0.00037	0.00105	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000367	0.00104	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000366	0.00104	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000365	0.00104	CcSEcCtD
Oxcarbazepine—Decreased appetite—Vincristine—lymphatic system cancer	0.000359	0.00102	CcSEcCtD
Oxcarbazepine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000358	0.00102	CcSEcCtD
Oxcarbazepine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000357	0.00101	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000356	0.00101	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000356	0.00101	CcSEcCtD
Oxcarbazepine—Fatigue—Vincristine—lymphatic system cancer	0.000356	0.00101	CcSEcCtD
Oxcarbazepine—Asthenia—Bleomycin—lymphatic system cancer	0.000356	0.00101	CcSEcCtD
Oxcarbazepine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000354	0.001	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000354	0.001	CcSEcCtD
Oxcarbazepine—Pain—Vincristine—lymphatic system cancer	0.000353	0.001	CcSEcCtD
Oxcarbazepine—Constipation—Vincristine—lymphatic system cancer	0.000353	0.001	CcSEcCtD
Oxcarbazepine—Asthma—Methotrexate—lymphatic system cancer	0.000352	0.001	CcSEcCtD
Oxcarbazepine—Pruritus—Bleomycin—lymphatic system cancer	0.000351	0.000995	CcSEcCtD
Oxcarbazepine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00035	0.000992	CcSEcCtD
Oxcarbazepine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000349	0.00099	CcSEcCtD
Oxcarbazepine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000347	0.000984	CcSEcCtD
Oxcarbazepine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000345	0.00098	CcSEcCtD
Oxcarbazepine—Constipation—Mitoxantrone—lymphatic system cancer	0.000344	0.000976	CcSEcCtD
Oxcarbazepine—Pain—Mitoxantrone—lymphatic system cancer	0.000344	0.000976	CcSEcCtD
Oxcarbazepine—Body temperature increased—Carmustine—lymphatic system cancer	0.000342	0.00097	CcSEcCtD
Oxcarbazepine—Abdominal pain—Carmustine—lymphatic system cancer	0.000342	0.00097	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000338	0.000958	CcSEcCtD
Oxcarbazepine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000335	0.000949	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000331	0.00094	CcSEcCtD
Oxcarbazepine—Dysuria—Methotrexate—lymphatic system cancer	0.000329	0.000935	CcSEcCtD
Oxcarbazepine—Neutropenia—Methotrexate—lymphatic system cancer	0.000329	0.000935	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000329	0.000933	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000327	0.000929	CcSEcCtD
Oxcarbazepine—Abdominal pain—Vincristine—lymphatic system cancer	0.000326	0.000926	CcSEcCtD
Oxcarbazepine—Body temperature increased—Vincristine—lymphatic system cancer	0.000326	0.000926	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000322	0.000912	CcSEcCtD
Oxcarbazepine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000319	0.000906	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000319	0.000904	CcSEcCtD
Oxcarbazepine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000318	0.000902	CcSEcCtD
Oxcarbazepine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000318	0.000902	CcSEcCtD
Oxcarbazepine—Pneumonia—Methotrexate—lymphatic system cancer	0.000316	0.000896	CcSEcCtD
Oxcarbazepine—Vomiting—Bleomycin—lymphatic system cancer	0.000315	0.000894	CcSEcCtD
Oxcarbazepine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000314	0.000891	CcSEcCtD
Oxcarbazepine—Infestation—Methotrexate—lymphatic system cancer	0.000314	0.000891	CcSEcCtD
Oxcarbazepine—Rash—Bleomycin—lymphatic system cancer	0.000312	0.000886	CcSEcCtD
Oxcarbazepine—Dermatitis—Bleomycin—lymphatic system cancer	0.000312	0.000886	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000311	0.000884	CcSEcCtD
Oxcarbazepine—Asthenia—Carmustine—lymphatic system cancer	0.00031	0.00088	CcSEcCtD
Oxcarbazepine—Renal failure—Methotrexate—lymphatic system cancer	0.000309	0.000876	CcSEcCtD
Oxcarbazepine—Stomatitis—Methotrexate—lymphatic system cancer	0.000306	0.000869	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000304	0.000863	CcSEcCtD
Oxcarbazepine—Haematuria—Methotrexate—lymphatic system cancer	0.000299	0.00085	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000297	0.000843	CcSEcCtD
Oxcarbazepine—Epistaxis—Methotrexate—lymphatic system cancer	0.000296	0.000841	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000296	0.000841	CcSEcCtD
Oxcarbazepine—Asthenia—Vincristine—lymphatic system cancer	0.000296	0.00084	CcSEcCtD
Oxcarbazepine—Diarrhoea—Carmustine—lymphatic system cancer	0.000296	0.00084	CcSEcCtD
Oxcarbazepine—Nausea—Bleomycin—lymphatic system cancer	0.000294	0.000835	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000293	0.000832	CcSEcCtD
Oxcarbazepine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000288	0.000819	CcSEcCtD
Oxcarbazepine—Dizziness—Carmustine—lymphatic system cancer	0.000286	0.000811	CcSEcCtD
Oxcarbazepine—Diarrhoea—Vincristine—lymphatic system cancer	0.000282	0.000802	CcSEcCtD
Oxcarbazepine—Hepatitis—Methotrexate—lymphatic system cancer	0.000282	0.0008	CcSEcCtD
Oxcarbazepine—Pharyngitis—Methotrexate—lymphatic system cancer	0.00028	0.000794	CcSEcCtD
Oxcarbazepine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000275	0.000781	CcSEcCtD
Oxcarbazepine—Vomiting—Carmustine—lymphatic system cancer	0.000275	0.00078	CcSEcCtD
Oxcarbazepine—Dizziness—Vincristine—lymphatic system cancer	0.000273	0.000775	CcSEcCtD
Oxcarbazepine—Rash—Carmustine—lymphatic system cancer	0.000273	0.000774	CcSEcCtD
Oxcarbazepine—Dermatitis—Carmustine—lymphatic system cancer	0.000272	0.000773	CcSEcCtD
Oxcarbazepine—Visual impairment—Methotrexate—lymphatic system cancer	0.000272	0.000771	CcSEcCtD
Oxcarbazepine—Headache—Carmustine—lymphatic system cancer	0.000271	0.000769	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000267	0.000756	CcSEcCtD
Oxcarbazepine—Eye disorder—Methotrexate—lymphatic system cancer	0.000264	0.000748	CcSEcCtD
Oxcarbazepine—Tinnitus—Methotrexate—lymphatic system cancer	0.000263	0.000746	CcSEcCtD
Oxcarbazepine—Vomiting—Vincristine—lymphatic system cancer	0.000263	0.000745	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000262	0.000743	CcSEcCtD
Oxcarbazepine—Rash—Vincristine—lymphatic system cancer	0.00026	0.000739	CcSEcCtD
Oxcarbazepine—Dermatitis—Vincristine—lymphatic system cancer	0.00026	0.000738	CcSEcCtD
Oxcarbazepine—Headache—Vincristine—lymphatic system cancer	0.000259	0.000734	CcSEcCtD
Oxcarbazepine—Nausea—Carmustine—lymphatic system cancer	0.000257	0.000729	CcSEcCtD
Oxcarbazepine—Angiopathy—Methotrexate—lymphatic system cancer	0.000256	0.000726	CcSEcCtD
Oxcarbazepine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000256	0.000725	CcSEcCtD
Oxcarbazepine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000255	0.000723	CcSEcCtD
Oxcarbazepine—Rash—Mitoxantrone—lymphatic system cancer	0.000254	0.000719	CcSEcCtD
Oxcarbazepine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000253	0.000719	CcSEcCtD
Oxcarbazepine—Chills—Methotrexate—lymphatic system cancer	0.000253	0.000718	CcSEcCtD
Oxcarbazepine—Headache—Mitoxantrone—lymphatic system cancer	0.000252	0.000715	CcSEcCtD
Oxcarbazepine—Alopecia—Methotrexate—lymphatic system cancer	0.000249	0.000707	CcSEcCtD
Oxcarbazepine—Mental disorder—Methotrexate—lymphatic system cancer	0.000247	0.000701	CcSEcCtD
Oxcarbazepine—Malnutrition—Methotrexate—lymphatic system cancer	0.000245	0.000696	CcSEcCtD
Oxcarbazepine—Nausea—Vincristine—lymphatic system cancer	0.000245	0.000696	CcSEcCtD
Oxcarbazepine—Dysgeusia—Methotrexate—lymphatic system cancer	0.00024	0.000682	CcSEcCtD
Oxcarbazepine—Nausea—Mitoxantrone—lymphatic system cancer	0.000239	0.000678	CcSEcCtD
Oxcarbazepine—Back pain—Methotrexate—lymphatic system cancer	0.000237	0.000674	CcSEcCtD
Oxcarbazepine—Vision blurred—Methotrexate—lymphatic system cancer	0.000231	0.000656	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000228	0.000646	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—lymphatic system cancer	0.000221	0.000628	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—lymphatic system cancer	0.000221	0.000626	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—lymphatic system cancer	0.00022	0.000623	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—lymphatic system cancer	0.000214	0.000608	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—lymphatic system cancer	0.000213	0.000603	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—lymphatic system cancer	0.000209	0.000593	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—lymphatic system cancer	0.000209	0.000593	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—lymphatic system cancer	0.000209	0.000593	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000208	0.000589	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—lymphatic system cancer	0.000206	0.000586	CcSEcCtD
Oxcarbazepine—Confusional state—Methotrexate—lymphatic system cancer	0.000202	0.000573	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.0002	0.000568	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—lymphatic system cancer	0.000199	0.000565	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000196	0.000557	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000196	0.000557	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—lymphatic system cancer	0.000195	0.000552	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000194	0.000549	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—lymphatic system cancer	0.000191	0.000542	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—lymphatic system cancer	0.000187	0.000531	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000183	0.000518	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—lymphatic system cancer	0.000181	0.000514	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000179	0.000507	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—lymphatic system cancer	0.000178	0.000505	CcSEcCtD
Oxcarbazepine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000176	0.0005	CcSEcCtD
Oxcarbazepine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000174	0.000494	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000173	0.000491	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—lymphatic system cancer	0.000173	0.00049	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—lymphatic system cancer	0.000171	0.000486	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000165	0.000468	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000164	0.000465	CcSEcCtD
Oxcarbazepine—Urticaria—Methotrexate—lymphatic system cancer	0.000159	0.000452	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000158	0.000449	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000158	0.000449	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000148	0.000419	CcSEcCtD
Oxcarbazepine—Asthenia—Methotrexate—lymphatic system cancer	0.000144	0.000408	CcSEcCtD
Oxcarbazepine—Pruritus—Methotrexate—lymphatic system cancer	0.000142	0.000402	CcSEcCtD
Oxcarbazepine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000137	0.000389	CcSEcCtD
Oxcarbazepine—Dizziness—Methotrexate—lymphatic system cancer	0.000132	0.000376	CcSEcCtD
Oxcarbazepine—Vomiting—Methotrexate—lymphatic system cancer	0.000127	0.000361	CcSEcCtD
Oxcarbazepine—Rash—Methotrexate—lymphatic system cancer	0.000126	0.000358	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—lymphatic system cancer	0.000126	0.000358	CcSEcCtD
Oxcarbazepine—Headache—Methotrexate—lymphatic system cancer	0.000126	0.000356	CcSEcCtD
Oxcarbazepine—Nausea—Methotrexate—lymphatic system cancer	0.000119	0.000338	CcSEcCtD
